| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
CLINICAL SCIENCE |
,¶

*Division of Nephrology, Nanfang Hospital, Guangzhou, Peoples Republic of China;
Department of Medicine, Duke University Medical Center, Durham, North Carolina;
Department of Surgery, Columbia University, College of Physicians and Surgeons, New York, New York;
Molecular and Cellular Nephrology, Institute of Medical Sciences, Tokai University School of Medicine, Isehara, Japan; and ¶Baxter Healthcare Corporation, Waukegan, Illinois.
Correspondence to Dr. Fan Fan Hou, Division of Nephrology, Nanfang Hospital, Guangzhou 510515, PR China. Phone: 86-20-61641591; Fax: 86-20-87281713; E-mail: ffhou{at}public.guangzhou.gd.cn
ABSTRACT. Inappropriate chronic inflammation associated with progressive, chronic kidney disease (CKD) reflects sustained activation of immunocompetent cells, like monocytes/macrophages. Advanced glycation end products (AGE) accumulate in CKD, but it is unclear if they stimulate monocytes by binding with the receptor for AGE (RAGE). Posited was the notion that RAGE plays a contributory role to monocyte-mediated systemic inflammation of progressive CKD. Peripheral blood monocytes were isolated from 102 patients without diabetes with varying severity of CKD. RAGE expression on peripheral blood monocytes increased with worsening CKD (r2 = 0.73) and was strongly correlated with plasma levels of pentosidine, a marker for AGE (r = 0.71). Strongly positive statistical correlations were observed in patients with CKD between monocyte RAGE and plasma levels of tumor necrosis factor alpha (TNF-
) (r = 0.61), the monocyte activation marker, neopterin (r = 0.65), and the systemic acute phase reactant, C-reactive protein (r = 0.44). Monocytes obtained from patients with CKD showed a monotonic increase in the number and affinity of specific AGE binding sites and increased production of TNF-
under stimulation of AGE. All these upregulatory responses in uremic monocytes could be largely blocked by an anti-RAGE antibody. It was concluded that RAGE expression was upregulated on monocytes from patients with CKD. Enhanced RAGE may amplify AGE-induced monocytes perturbation and contribute to monocyte-mediated systemic inflammation in progressive CKD.
This article has been cited by other articles:
![]() |
L. F Brown and C. G Fraser Assay validation and biological variation of serum receptor for advanced glycation end-products Ann Clin Biochem, September 1, 2008; 45(5): 518 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zen, C. X.-J. Chen, Y.-T. Chen, R. Wilton, and Y. Liu Receptor for Advanced Glycation Endproducts Mediates Neutrophil Migration across Intestinal Epithelium J. Immunol., February 15, 2007; 178(4): 2483 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Vincent, L. Perrone, K. A. Sullivan, C. Backus, A. M. Sastry, C. Lastoskie, and E. L. Feldman Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress Endocrinology, February 1, 2007; 148(2): 548 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Verkade, C. J. van Druningen, L. M. B. Vaessen, D. A. Hesselink, W. Weimar, and M. G. H. Betjes Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease Nephrol. Dial. Transplant., January 1, 2007; 22(1): 128 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. X. Liu, F. F. Hou, Z. J. Guo, R. Nagai, W. R. Zhang, Z. Q. Liu, Z. M. Zhou, M. Zhou, D. Xie, G. B. Wang, et al. Advanced Oxidation Protein Products Accelerate Atherosclerosis Through Promoting Oxidative Stress and Inflammation Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1156 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stam, C. G. Schalkwijk, C. van Guldener, P. M. ter Wee, and C. D. A. Stehouwer Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals Nephrol. Dial. Transplant., March 1, 2006; 21(3): 677 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Chade, A. Lerman, and L. O. Lerman Kidney in Early Atherosclerosis Hypertension, June 1, 2005; 45(6): 1042 - 1049. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673